A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with type 2 diabetes, impaired glucose metabolism and insulin levels

Journal of Human Genetics

Volumn 51, Issue 6, 2006, Pages 567-574

  Rubin, Diana ^a,b   Helwig, Ulf ^a,b   Pfeuffer, Maria ^a   Schreiber, Stefan ^c   Boeing, Heiner ^d   Fisher, Eva ^d   Pfeiffer, Andreas ^d   Freitag Wolf, Sandra ^b   Foelsch, Ulrich R ^b   Doering, Frank ^c   Schrezenmeir, Juergen ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Insulin; Metabolic Intervention Cohort Kiel; Microsomal triglyceride transfer protein; Polymorphism; Postprandial metabolism; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN B; DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; DYSLIPIDEMIA; EXON; FEMALE; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; HOMOZYGOTE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

AGED; ALLELES; BLOOD GLUCOSE; CARRIER PROTEINS; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EXONS; GENE FREQUENCY; GERMANY; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33745454996     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-006-0400-y     Document Type: Article

References (44)

1. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
2. Austin MA, Talmud PJ, Luong LA, Haddad L, Day IN, Newman B, Edwards KL, Krauss RM, Humphries SE (1998) Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am J Hum Genet 62:406-419
3. Bakillah A, El Abbouyi A (2003) The role of microsomal triglyceride transfer protein in lipoprotein assembly: an update. Front Biosci 8:d294-d305
4. Bernard S, Touzet S, Personne I, Lapras V, Bondon PJ, Berthezene F, Moulin P (2000) Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia 43:995-999
5. Boeing H, Korfmann A, Bergmann MM (1999) Recruitment procedures of EPIC-Germany. European investigation into cancer and nutrition. Ann Nutr Metab 43:205-215
6. Callaway C, Chumlea W, Bouchard C (1988) Anthropometric standardization reference manual. Human Kinetics, Champaign, IL, pp 39-54
7. Carpentier A, Taghibiglou C, Leung N, Szeto L, Van Iderstine SC, Uffelman KD, Buckingham R, Adeli K, Lewis GF (2002) Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277:28795-28802
8. Chan DC, Barrett PH, Watts GF (2004) Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods. Clin Sci (Lond) 107:233-249
9. Chang BH, Liao W, Li L, Nakamuta M, Mack D, Chan L (1999) Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knockout mouse. J Biol Chem 274:6051-6055
10. Chen SP, Tan KC, Lam KS (2003) Effect of the microsomal triglyceride transfer protein -493 G/T polymorphism and type 2 diabetes mellitus on LDL subfractions. Atherosclerosis 167:287-292
11. Couture P, Otvos JD, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM (2000) Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis 148:337-343
12. Gordon DA, Jamil H, Gregg RE, Olofsson SO, Boren J (1996) Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step. J Biol Chem 271:33047-33053
13. Haidari M, Leung N, Mahbub F, Uffelman KD, Kohen-Avramoglu R, Lewis GF, Adeli K (2002) Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem 277:31646-31655
14. Juo SH, Han Z, Smith JD, Colangelo L, Liu K (2000) Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, ApoB, and triglyceride levels in young African American men: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Arterioscler Thromb Vasc Biol 20:1316-1322
15. Juo SH, Colangelo L, Han Z, Smith JD, Liu K (2003) Confirmation of the microsomal triglyceride transfer protein genetic effect on lipids in young African American men from the CARDIA study. Arterioscler Thromb Vasc Biol 23:912-913
16. Karpe F, Lundahl B, Ehrenborg E, Eriksson P, Hamsten A (1998) A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol 18:756-761
17. Klipstein-Grobusch K, Georg T, Boeing H (1997) Interviewer variability in anthropometric measurements and estimates of body composition. Int J Epidemiol 26(Suppl 1):S174-S180
18. Ledmyr H (2004) Molecular regulation of microsomal triglyceride transfer protein gene, MTP: functional genetic studies in relation to cardiovascular disease. Doktosavhandling fran Karoliska Institutet. ISBN 91-7140-142-3
19. Ledmyr H, Karpe F, Lundahl B, McKinnon M, Skoglund-Andersson C, Ehrenborg E (2002) Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. J Lipid Res 43:51-58
20. Ledmyr H, McMahon AD, Ehrenborg E, Nielsen LB, Neville M, Lithell H, MacFarlane PW, Packard CJ, Karpe F (2004) The microsomal triglyceride transfer protein gene -493T variant lowers cholesterol but increases the risk of coronary heart disease. Circulation 109:2279-2284
21. Leung GK, Veniant MM, Kim SK, Zlot CH, Raabe M, Bjorkegren J, Neese RA, Hellerstein MK, Young SG (2000) A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion. J Biol Chem 275:7515-7520
22. Lin MC, Gordon D, Wetterau JR (1995) Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res 36:1073-1081
23. Lundahl B, Leren TP, Ose L, Hamsten A, Karpe F (2000) A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 20:1784-1788
24. Lundahl B, Hamsten A, Karpe F (2002) Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene. Arterioscler Thromb Vasc Biol 22:289-293
25. Namikawa C, Shu-Ping Z, Vyselaar JR, Nozaki Y, Nemoto Y, Ono M, Akisawa N, Saibara T, Hiroi M, Enzan H, Onishi S (2004) Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 40:781-786
26. Nebel A, Croucher PJ, Stiegeler R, Nikolaus S, Krawczak M, Schreiber S (2005) No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans. Proc Natl Acad Sci USA 102:7906-7909
27. Perusse L, Rice T, Chagnon YC, Despres JP, Lemieux S, Roy S, Lacaille M, Ho-Kim MA, Chagnon M, Province MA, Rao DC, Bouchard C (2001) A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family Study. Diabetes 50:614-621
28. Raabe M, Veniant MM, Sullivan MA, Zlot CH, Bjorkegren J, Nielsen LB, Wong JS, Hamilton RL, Young SG (1999) Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 103:1287-1298
29. Riccardi G, Giacco R, Rivellese AA (2004) Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23:447-456
30. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865
31. Rustaeus S, Stillemark P, Lindberg K, Gordon D, Olofsson SO (1998) The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells. J Biol Chem 273:5196-5203
32. Schrezenmeir J, Keppler I, Fenselau S, Weber P, Biesalski HK, Probst R, Laue C, Zuchhold HD, Prellwitz W, Beyer J (1993) The phenomenon of a high triglyceride response to an oral lipid load in healthy subjects and its link to the metabolic syndrome. Ann NY Acad Sci 683:302-314
33. Sposito AC, Gonbert S, Turpin G, Chapman MJ, Thillet J (2004) Common polymorphism in the MTP promoter attenuates the dyslipidemic and proatherogenic effects of excess body weight. Arterioscler Thromb Vasc Biol 24:e143
34. Stan S, Lambert M, Delvin E, Paradis G, O'Loughlin J, Hanley JA, Levy E (2005) Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth. J Lipid Res 46:320-327
35. St-Pierre J, Lemieux I, Miller-Felix I, Prud'homme D, Bergeron J, Gaudet D, Nadeau A, Despres JP, Vohl MC (2002) Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein levels in men. Atherosclerosis 160:317-324
36. Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K (2000) Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275:8416-8425
37. Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, Le-Tien H, Fantus IG, Lewis GF, Adeli K (2002) Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 277:793-803
38. Talmud PJ, Palmen J, Miller G, Humphries SE (2000) Effect of microsomal triglyceride transfer protein gene variants (-493G > T, Q95H and H297Q) on plasma lipid levels in healthy middle-aged UK men. Ann Hum Genet 64:269-276
39. Taskinen MR (2002) Diabetic dyslipidemia. Atheroscler Suppl 3:47-51
40. Tietge UJ, Bakillah A, Maugeais C, Tsukamoto K, Hussain M, Rader DJ (1999) Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res 40:2134-2139
41. Verges BL (1999) Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab 25(Suppl 3):32-40
42. Vincent S, Planells R, Defoort C, Bernard MC, Gerber M, Prudhomme J, Vague P, Lairon D (2002) Genetic polymorphisms and lipoprotein responses to diets. Proc Nutr Soc 61:427-434
43. Wetterau JR, Lin MC, Jamil H (1997) Microsomal triglyceride transfer protein. Biochim Biophys Acta 1345:136-150
44. Wetterau JR, Gregg RE, Harrity TW, Arbeeny C, Cap M, Connolly F, Chu CH, George RJ, Gordon DA, Jamil H, Jolibois KG, Kunselman LK, Lan SJ, Maccagnan TJ, Ricci B, Yan M, Young D, Chen Y, Fryszman OM, Logan JV, Musial CL, Poss MA, Robl JA, Simpkins LM, Slusarchyk WA, Sulsky R, Taunk P, Magnin DR, Tino JA, Lawrence RM, Dickson JK Jr, Biller SA (1998) An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science 282:751-754